- New
SLU-PP-332 5 mg · Lyophilised vial
Injectable ERR agonist — exercise-mimetic research.
Triple-agonist for appetite and body recomposition.
Triple-agonist for appetite and body recomposition. Active: Retatrutide. Strength: 10 mg. Form: Lyophilised vial. Route: Subcutaneous. Class: Triple agonist. Supplied under the Hexal-OZ line. Priced in AUD; paid in crypto via BTCPay (XMR preferred, BTC secondary).
Data sheet
Injectable ERR agonist — exercise-mimetic research.
Body Protection Compound. Tissue and gut repair.
The complete recovery stack in one vial.
Double kit of recombinant somatropin. Best value per IU.
HGH fragment studied for fat metabolism.
Mitochondrial peptide for metabolism and endurance.
Tanning and pigmentation research peptides.
Stimulates the natural LH/FSH hormone axis.
50 mg GHK-Cu · 10 mg TB-500 · 10 mg BPC-157 in one vial.
Immune-modulating thymic peptide.
Clean, selective GH pulse with minimal sides.
Anti-inflammatory and gut-health tripeptide.
Systemic recovery and flexibility. Pairs with BPC-157.
Pre-filled retatrutide pen — GLP-1/GIP/glucagon.